kinesin spindle protein inhibitors (Bristol-Myers Squibb)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namekinesin spindle protein inhibitors (Bristol-Myers Squibb)
Drug Alias Namekinesin Eg5 inhibitors (Bristol-Myers Squibb)BMS-466411BMS-191096BMS-601027
ClassificationSmall molecules
Mechanisms of ActionCell cycle inhibitorsKinesin-like protein 1 inhibitors
TargetsKinesin-like protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A